BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 20029944)

  • 1. Genetic polymorphisms in the metabolic pathway and non-Hodgkin lymphoma survival.
    Han X; Zheng T; Foss FM; Lan Q; Holford TR; Rothman N; Ma S; Zhang Y
    Am J Hematol; 2010 Jan; 85(1):51-6. PubMed ID: 20029944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms in immune function genes and non-Hodgkin lymphoma survival.
    Aschebrook-Kilfoy B; Zheng T; Foss F; Ma S; Han X; Lan Q; Holford T; Chen Y; Leaderer B; Rothman N; Zhang Y
    J Cancer Surviv; 2012 Mar; 6(1):102-14. PubMed ID: 22113576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-acetyltransferase polymorphisms are associated with risk of lymphoma subtypes.
    Cocco P; Zucca M; Sanna S; Satta G; Nonne T; Angelucci E; Gabbas A; Rais M; Malpeli G; Campagna M; Scarpa A; G Ennas M
    Hematol Oncol; 2016 Jun; 34(2):79-83. PubMed ID: 25689677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variations in xenobiotic metabolic pathway genes, personal hair dye use, and risk of non-Hodgkin lymphoma.
    Zhang Y; Hughes KJ; Zahm SH; Zhang Y; Holford TR; Dai L; Bai Y; Han X; Qin Q; Lan Q; Rothman N; Zhu Y; Leaderer B; Zheng T
    Am J Epidemiol; 2009 Nov; 170(10):1222-30. PubMed ID: 19822571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic polymorphisms in GST genes and survival of colorectal cancer patients treated with chemotherapy.
    Funke S; Timofeeva M; Risch A; Hoffmeister M; Stegmaier C; Seiler CM; Brenner H; Chang-Claude J
    Pharmacogenomics; 2010 Jan; 11(1):33-41. PubMed ID: 20017670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of CYP2E1, GSTA1 and GSTP1 gene variants on serum alpha glutathione S-transferase level in patients undergoing anaesthesia.
    Mikstacki A; Skrzypczak-Zielinska M; Zakerska-Banaszak O; Tamowicz B; Skibinska M; Molinska-Glura M; Szalata M; Slomski R
    BMC Med Genet; 2016 May; 17(1):40. PubMed ID: 27179909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic polymorphisms of CYP2E1, GST, and NAT2 enzymes are not associated with risk of breast cancer in a sample of Lebanese women.
    Zgheib NK; Shamseddine AA; Geryess E; Tfayli A; Bazarbachi A; Salem Z; Shamseddine A; Taher A; El-Saghir NS
    Mutat Res; 2013; 747-748():40-7. PubMed ID: 23628324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glutathione-S-transferase genotypes influence prognosis in follicular non-Hodgkin's Lymphoma.
    Hohaus S; Mansueto G; Massini G; D'Alo F; Giachelia M; Martini M; Larocca LM; Voso MT; Leone G
    Leuk Lymphoma; 2007 Mar; 48(3):564-9. PubMed ID: 17454600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of polymorphisms of GSTM1, GSTT1 and GSTP1 Ile105Val in Hodgkin and non-Hodgkin lymphoma risk: a Human Genome Epidemiology (HuGE) review.
    Bin Q; Luo J
    Leuk Lymphoma; 2013 Jan; 54(1):14-20. PubMed ID: 22734843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic variation in N-acetyltransferases 1 and 2, cigarette smoking, and risk of non-Hodgkin lymphoma.
    Kilfoy BA; Zheng T; Lan Q; Han X; Holford T; Hein DW; Qin Q; Leaderer B; Morton LM; Yeager M; Boyle P; Zhao P; Chanock S; Rothman N; Zhang Y
    Cancer Causes Control; 2010 Jan; 21(1):127-33. PubMed ID: 19809881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic interaction between NAT2, GSTM1, GSTT1, CYP2E1, and environmental factors is associated with adverse reactions to anti-tuberculosis drugs.
    Costa GN; Magno LA; Santana CV; Konstantinovas C; Saito ST; Machado M; Di Pietro G; Bastos-Rodrigues L; Miranda DM; De Marco LA; Romano-Silva MA; Rios-Santos F
    Mol Diagn Ther; 2012 Aug; 16(4):241-50. PubMed ID: 22788240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smoking, variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma: a pooled analysis within the InterLymph consortium.
    Gibson TM; Smedby KE; Skibola CF; Hein DW; Slager SL; de Sanjosé S; Vajdic CM; Zhang Y; Chiu BC; Wang SS; Hjalgrim H; Nieters A; Bracci PM; Kricker A; Zheng T; Kolar C; Cerhan JR; Darabi H; Becker N; Conde L; Holford TR; Weisenburger DD; De Roos AJ; Butterbach K; Riby J; Cozen W; Benavente Y; Palmers C; Holly EA; Sampson JN; Rothman N; Armstrong BK; Morton LM
    Cancer Causes Control; 2013 Jan; 24(1):125-34. PubMed ID: 23160945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutathione S-transferase M1, T1 and P1 polymorphisms: susceptibility and outcome in lung cancer patients.
    Sreeja L; Syamala V; Hariharan S; Syamala VS; Raveendran PB; Sivanandan CD; Madhavan J; Ankathil R
    J Exp Ther Oncol; 2008; 7(1):73-85. PubMed ID: 18472644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms of glutathione-S-transferase and arylamine N-acetyltransferase enzymes and susceptibility to colorectal cancer.
    Kiss I; Németh A; Bogner B; Pajkos G; Orsós Z; Sándor J; Csejtey A; Faluhelyi Z; Rodler I; Ember I
    Anticancer Res; 2004; 24(6):3965-70. PubMed ID: 15736440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutathione S-Transferase Gene Polymorphisms and Treatment Outcome in Cervical Cancer Patients under Concomitant Chemoradiation.
    Abbas M; Kushwaha VS; Srivastava K; Banerjee M
    PLoS One; 2015; 10(11):e0142501. PubMed ID: 26571237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GST, NAT1, CYP1A1 polymorphisms and risk of esophageal and gastric adenocarcinomas.
    Wideroff L; Vaughan TL; Farin FM; Gammon MD; Risch H; Stanford JL; Chow WH
    Cancer Detect Prev; 2007; 31(3):233-6. PubMed ID: 17646057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical implications of glutathione S-transferase genotyping in patients with diffuse large B-cell lymphoma.
    Atanaskovic L; Cikota-Aleksic B; Tarabar O; Trimcev J; Zivanovic-Ivic A; Marjanovic S; Magic Z
    J BUON; 2016; 21(6):1459-1465. PubMed ID: 28039708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms in NAT2 and GSTP1 are associated with survival in oral and oropharyngeal cancer.
    Troy JD; Weissfeld JL; Diergaarde B; Youk AO; Buch SC; Romkes M; Grandis JR
    Cancer Epidemiol; 2013 Aug; 37(4):505-11. PubMed ID: 23523331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between glutathione S-transferase M1, T1, and P1 polymorphisms and chronic lymphocytic leukemia.
    Yuille M; Condie A; Hudson C; Kote-Jarai Z; Stone E; Eeles R; Matutes E; Catovsky D; Houlston R
    Blood; 2002 Jun; 99(11):4216-8. PubMed ID: 12010828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of genetic polymorphisms in glutathione-S-transferases gene in response to imatinib among Brazilian patients with chronic myeloid leukemia.
    Delmond KA; Delleon H; Goveia RM; Teixeira TM; Abreu DC; Mello-Andrade F; Reis AADS; Silva DME; Barbosa ADP; Tavares RS; Anunciação CE; Silveira-Lacerda E
    Mol Biol Rep; 2021 Mar; 48(3):2035-2046. PubMed ID: 33709282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.